HHS won't act against pharmacies making 6 unapproved peptides

The US' health department, HHS, has said it will not take enforcement action against licensed pharmacies and physicians compounding six unapproved peptides, including BPC-157 and TB-500. An FDA advisory panel backed the peptides in July, though FDA staff had recommended against it. The department said compounded drugs are not FDA-approved and the policy is interim.